MED Stock Overview
Mediplantex National Pharmaceutical Joint Stock Company operates as a pharmaceutical company in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Mediplantex National Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫25,000.00 |
| 52 Week High | ₫28,000.00 |
| 52 Week Low | ₫21,100.00 |
| Beta | 0.043 |
| 1 Month Change | 2.46% |
| 3 Month Change | n/a |
| 1 Year Change | -3.85% |
| 3 Year Change | -38.12% |
| 5 Year Change | n/a |
| Change since IPO | -48.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| MED | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | -3.8% |
| 1Y | -3.8% | 24.3% | 14.1% |
Return vs Industry: MED underperformed the VN Pharmaceuticals industry which returned 24.8% over the past year.
Return vs Market: MED underperformed the VN Market which returned 14.6% over the past year.
Price Volatility
| MED volatility | |
|---|---|
| MED Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 3.4% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in VN Market | 7.0% |
| 10% least volatile stocks in VN Market | 2.3% |
Stable Share Price: MED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MED's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | n/a | n/a | www.mediplantex.com |
Mediplantex National Pharmaceutical Joint Stock Company operates as a pharmaceutical company in Vietnam. It provides pharmaceutical products in various categories, including drugs from herbals, analgesics - corticosteroid - anti-inflammatory, antibiotics, anti-malarial and demostasis drugs, gout-diabetes drugs, allergies and osteoarthritis drugs, and acid amin-vitamins and minerals, as well as cerebral circulation, heart, and lung drugs. The company also offers medicinal plant products; and extracting and semi synthetic materials, such as essential oils.
Mediplantex National Pharmaceutical Joint Stock Company Fundamentals Summary
| MED fundamental statistics | |
|---|---|
| Market cap | ₫310.25b |
| Earnings (TTM) | ₫11.84b |
| Revenue (TTM) | ₫399.96b |
26.2x
P/E Ratio0.8x
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MED income statement (TTM) | |
|---|---|
| Revenue | ₫399.96b |
| Cost of Revenue | ₫316.92b |
| Gross Profit | ₫83.05b |
| Other Expenses | ₫71.21b |
| Earnings | ₫11.84b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 953.85 |
| Gross Margin | 20.76% |
| Net Profit Margin | 2.96% |
| Debt/Equity Ratio | 19.7% |
How did MED perform over the long term?
See historical performance and comparison